Navigation Links
Micell Technologies Presents Data on Novel Drug-Eluting Stents

number of issues including inherently thrombogenic polymers, residual drugs and patient compliance issues related to the necessary oral anti-platelet therapy such as Plavix and aspirin, required of patients who receive drug-eluting stents.

"Our technology provides an opportunity for optimal design of therapeutic profiles using both anti-restenosis and anti-thrombotic compounds to address both short and long-term safety of drug-eluting stents," said James B. McClain, founder and Chief Technology Officer of Micell Technologies. "This approach which includes multi-drug formulations in biodegradable polymers has the potential to provide improved benefits for both patients and clinicians."

Micell Technologies' novel approach to surface modification of medical devices provides an opportunity to deliver the next generation of drug-eluting stents by maintaining morphology of therapeutic compounds and providing manufacturing processes that apply discrete and independent therapies within a single, multi-therapy coating.

About Micell

Micell Technologies is a privately-held, early-stage biomedical company dedicated to applying its unique surface and polymer modification technologies for improved patient benefits and accelerated product development for medical device and drug delivery applications. The Company's patented processes and methods for medical device surface modification using supercritical fluids are focused on improvements to current polymer based drug-eluting technologies. To learn more, please visit our website at www.micell.com

Contact: James McClain Ph.D., Chief Technology Officer

Micell Technologies: (919) 313-2111

CONTACT: James McClain Ph.D., Chief Technology Officer of MicellTechnologies, +1-919-313-2111

Web site: http://www.micell.com/

Terms and conditions of use apply

'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
4. Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction
5. Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
6. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
7. AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
8. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
11. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Micell Technologies Presents Data Novel Drug Eluting Stents
(Date:12/1/2009)... , ATLANTA, Dec. 1 C...edical device and cardiovascular tissue processing... for 2010. ,, The Company expects total revenue...illion and $123.0 million, which includes between ...eceived from the Department of Defense in connecti...
(Date:12/1/2009)... , PISCATAWAY, N.J., Dec. 1 ...ens.com/hearing) a leading global manufacturer of ...rtnership with Quota International,s Sound Beginni...h September 2010. ,, As part of the renewed par...ide vouchers for 100 free hearing instruments to b...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/ ...provider of biopharmaceutical products in China, a...chase order for its H1N1 vaccine, PANFLU.1(TM),fr...chnology for the national,purchase plan. Under thi...n,additional one million doses of PANFLU.1 (TM) (1...
Breaking Medicine Technology:CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 1Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 2Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 3Radiation From Medical Scans Soaring 60144 1Radiation From Medical Scans Soaring 60144 2Radiation From Medical Scans Soaring 60144 3Relevant Security and bitRail Debut RevSecure Product Line 60142 1Relevant Security and bitRail Debut RevSecure Product Line 60142 2Relevant Security and bitRail Debut RevSecure Product Line 60142 3Relevant Security and bitRail Debut RevSecure Product Line 60142 4
(Date:12/1/2009)...ould identify those who would benefit from liver s...ESDAY, Dec. 1 (HealthDay News) -- A CT scan of liv...r may help predict overall survival after chemothe...(Avastin) to cytotoxic chemotherapy has been shown...olorectal cancer and to produce better results in ...
(Date:12/1/2009)... Practitioners of any medi...nscription are breathing a sigh of relief this wee...Phone. The application, released over the holiday...anscribe voice recordings to do so quickly and sea... (PRWEB) December 1, 2009 -- The ...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNews... of patient enrollment in the randomized clinical ...g Stent (Combo Stent). ,, A prospective, random... E valuation of an ablu M inal sirolimus coat ... patients at up to 20 sites in Asia, Australia, Eu...
(Date:12/1/2009)... Montreal, December 1, 2009 A Universit de Montra...arch Center on Family Violence and Violence Agains...ffects of pornography on men. "We started our rese...onsumed pornography. We couldn,t find any," says S...professor at the School of Social Work. , "The ...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2
...C., Oct. 30 It,s no secret that,companies rely he... top,talent. But best-in-class organizations have ... hiring opportunities, according to research from,...izations and, ultimately, into their,work forces. ...
..., Oct. 30 West Anaheim Medical,Center, an affilia...nstalled a state-of-the-art patient tracking and i...ent. Housed within the hospital,s MEDITECH,system,... and efficiently. This patient safety process take...
...A) Specifically aimed, stereotactic radiation may ...ter in treating benign but potentially devastatin...cording to a study by rradiation oncologists at th...ent is effective and the only way to remove the t...
...erts from the U.S Centers for Disease Control, Uni...: HIV Symposium at Association for Molecular Patho...Nov. 7, 9:00 to 10:00 am , Where: Hyatt Regency ... been concerned about HIVs ability to mutate and c...
... and analysis reveal how salaries measure up acros...LADELPHIA, Oct. 30 Case in Point Magazine announc...and Trends Survey.,Presenting professional demogra...prevailing trends. Anne Llewellyn,RN-BC, MS, BHSA,...
... Oct 30 Perrigo Company,(Nasdaq: PRGO ; TASE) to... a,quarterly dividend of $0.05 per share, payable ...November 23, 2007. The new quarterly dividend of,$...care supplier that develops,manufactures and distr...
Other Medicine News:Health News:Lessons Learned in Securing Top Talent During University Recruiting 2Health News:Hospital Launches State-of-the-Art Patient Tracking and Integrated Patient Data System 2Health News:Jefferson oncologists show focused radiation is effective as surgery against nerve tumor 2Health News:Case in Point Magazine Releases 2007 Case Management Salary and Trends Survey 2
...fered as 1-piece or modular, in regular or extra l...ized with handles of choice and other options such...ndard patterns are available from Mediflex stock. ... , Please Note: Individual instrument components...
10 mm Babcock-Debakey Forceps
Babcock Grasper
...ts incorporate a layered design unique in the indu...o prevent stray electrosurgical burns along the sh... or capacitive coupling; a well-documented patient... AEM Instruments provides a neutral return path fo...
Medicine Products: